# Levetiracetam

## Keppra 500mg

| 藥物代碼 | OKEP |
| :--- | :--- |
| 適應症 | Focal \(partial\) onset: Adjunctive therapy in the treatment of focal \(partial\) onset seizures in adults and children ?4 years of age and &gt;20 kg with epilepsy. Generalized onset: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years and older with juvenile myoclonic epilepsy. Primary generalized tonic-clonic seizures: Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and 16 years and older with idiopathic generalized epilepsy. |
| 副作用 | CommonGastrointestinal: Loss of appetite \(3% to 8% \), Vomiting \(15% \)Immunologic: Infectious disease \(13% \)Musculoskeletal: Decreased bone mineral density \(70% \), Neck pain \(2% to 8% \)Neurologic: Asthenia \(15% \), Dizziness \(5% to 9% \), Headache \(14% to 19% \)Psychiatric: Abnormal behavior \(7% to 37.6% \), Irritability \(6% to 12% \)Respiratory: Cough \(2% to 9% \), Nasopharyngitis \(7% to 15% \)Other: Fatigue \(10% to 11% \)SeriousDermatologic: Stevens-Johnson syndrome, Toxic epidermal necrolysis due to drugHematologic: Decreased erythrocyte production, Decreased white blood cell count \(2.4% to 3.2% \), Eosinophil count raised \(8.6% \), Neutropenia \( 2.4% \), Pancytopenia, ThrombocytopeniaHepatic: Liver failureImmunologic: AnaphylaxisNeurologic: Somnolence \(8% to 45% \)Psychiatric: Suicidal intent \(0.5% \), SuicideOther: Angioedema |
| 禁忌 | Hypersensitivity to levetiracetam. |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest risk |
| 附帶說明 | \[仿單\]在一大量上市後資料中，接受 levetiracetam 單一治療的孕婦（超過 1800 例，其中超過 1500 例發生在懷孕的前三個月期間）主要先天性畸形的風險並未增加。 關於在子宮內接受 levetiracetam 單一治療的兒童神經發育，目前僅有有限的證據。但目前流行病學研究（約 100 名兒童）並未有神經發育障礙或延遲的風險增加。 Levetiracetam 如果在經仔細評估後認為它是臨床上所需要時，才可以在懷孕期間使用。 在這種情況下，建議使用最低有效劑量。懷孕期間的生理變化也可能會影響 levetiracetam 的濃度。 曾有在懷孕期間出現血漿中 levetiracetam 濃度降低現象的報告。這種濃度降低的現象在第三孕期會更為顯著\(降低程度最高可達懷孕前之基礎濃度的 60%\)。 請務必為接受治療的懷孕婦女進行適當的臨床處置。 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | \[仿單\] Levetiracetam 會排泄至人類乳汁中，故不建議授乳。 但如果在授乳期間需要服用levetiracetam，須評估治療效益及風險與授乳的重要性。 |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

